WuXi AppTec falls as US Senate bill on Chinese biotech firms moves forward

WuXi Biologics (Cayman)

07/03/2024 05:37

(Updates)
    ** WuXi AppTec Hong Kong shares  2359.HK  fall as much as
20.6% to HK$45, lowest since Feb. 21
    ** Second-biggest pct loser in Hang Seng Index  .HSI   
    ** Shanghai shares  603259.SS  open down as much as 10% 
    ** U.S. Senate's homeland security committee voted on
Wednesday to approve a bill that could restrict business with
Chinese biotech companies like BGI and WuXi AppTec on national
security grounds 
    ** Shares of WuXi Biologics  2269.HK  fall as much as 21.3%
to HK$17.12, lowest since Feb. 21
        ** WuXi XDC  2268.HK , a unit of WuXi Biologics, drop
18.8% to HK$18.84
  
    ** WuXi AppTec, WuXi Biologics say they do not have human
genomics business or collect human genomics data, and they have
not posed, do not pose, and will not pose a security risk to
U.S. or any other country 
    ** WuXi AppTec's Hong Kong stock falls 40.2% YTD, WuXi
Biologics drops 41.8% YTD, WuXi XDC down 38.8% YTD  

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))